Macrolide Therapy to Improve Forced Expiratory Volume in 1 Second in Adults With Sickle Cell Disease

Clinical Trial ID NCT02960503

Rank	Title	Journal	Year	PubWeight™‹?›
1	Mortality in sickle cell disease. Life expectancy and risk factors for early death.	N Engl J Med	1994	15.82
2	Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.	N Engl J Med	2004	10.51
3	Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations.	Eur Respir J	2012	7.18
4	Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group.	N Engl J Med	2000	6.07
5	Pathogenesis and treatment of sickle cell disease.	N Engl J Med	1997	4.04
6	Asthma is associated with increased mortality in individuals with sickle cell anemia.	Haematologica	2007	1.74
7	Asthma and sickle cell disease: two distinct diseases or part of the same process?	Hematology Am Soc Hematol Educ Program	2009	1.07
8	NT-pro brain natriuretic peptide levels and the risk of death in the cooperative study of sickle cell disease.	Br J Haematol	2011	0.96
9	Low forced expiratory volume is associated with earlier death in sickle cell anemia.	Blood	2015	0.79
10	Azithromycin.	Profiles Drug Subst Excip Relat Methodol	2014	0.78